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Introduction
Obesity continues to be a major health 
care problem in the US and adults spend 
over $30 billion yearly in weight loss 
products and services.1 The use of dietary 
supplements (DS), including herbal 
constituents such as Hydroxycut, has 
become a major health trend in affluent 
societies. Consumption of DS in the USA 
has doubled between 1999 and 2004 with 
18.9% of adults admitting their use.1 DS are 
expected to meet the standards outlined in 
the Dietary Supplement and Health 
Education Act of 1994 which allows 
distribution without prior approval of their 
efficacy and safety by the Food and Drug 
Administration (FDA).2 This simplified 
licensing practice does not ensure efficacy 
and safety in the same strict way as with the 
approval of conventional medications and 
treatments. Therefore, risks of these drugs 
causing potentially life threatening side 
effects may go unreported. 
 
Case Report 
A 28-year-old male with no known 
medical problems presented with a two-day 
history of abdominal pain, nausea, and 
vomiting. The pain was made worse with 
meals.  He denied fever, chills, diarrhea, and 
constipation. He did not have any risk 
factors for hepatitis infection and denied any 
recent travel, alcoholism, or drug overdose.   
The initial exam essentially was normal, 
except for epigastric and right upper 
quadrant tenderness. Initial pertinent 
laboratory showed  a white blood count of 
8.1x103/L, an aspartate aminotransferase 
(AST) of 567 IU/L, alanine amino-
transferase (ALT) of 281 IU/L, alkaline 
phosphatase of 586 IU/L, international 
normalized ratio of 1, total bilirubin of 5.4 
mg/dL, conjugated bilirubin of 4.4 mg/dL, 
lipase of 103/µL, C-reactive protein of 48 
mg, and acetaminophen was less than 2 
mcg/ml. Hepatitis B surface antigen, 
hepatitis C antibody, and hepatitis A IgM 
were negative.  
The patient improved with conservative 
management and was discharged. However, 
he presented three days later with similar 
symptoms. Laboratory work was consistent 
with hepatitis (ALT of 380 IU/L and AST of 
283 IU/L) and pancreatitis with lipase of 
722 U/L. His right upper quadrant 
ultrasound showed no evidence of 
cholelithiasis. Further workup was negative 
for blood alcohol level, varicella zoster 
virus, herpes simplex virus, autoimmune 
hepatitis, hemochromatosis, and Wilson’s 
disease.   
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Magnetic resonance cholangiopancreato-
graphy did not show any filling defects in 
the bile ducts. Liver biopsy showed 
steatosis, necrosis, and eosinophilic 
infiltrates (Figures 1 and 2). These findings 
were non-specific, but suggestive of drug-
induced liver injury.  On further inquiry, the 
patient revealed taking Hydroxycut over the 
preceding three weeks. He was advised to 
stop taking Hydroxycut and his AST and 
ALT normalized in 6 to 8 weeks. 
 
 
Figure 1. Liver biopsy showing steatosis. 
 
 
Figure 2. Liver biopsy showing intact portal 
triad and eosinophilic infiltration. 
 
Discussion 
Hydroxycut is an herbal dietary 
supplement used for weight loss. 
Hepatotoxicity is a well-established side 
effect of Hydroxycut. The exact incidence of 
Hydroxycut induced hepatitis is unknown 
with over 23 cases reported in literature to 
our knowledge.3-4 Other rare but recognized 
side effects of Hydroxycut, such as atrial 
fibrillation, also have been reported in the 
literature.5 However, to our knowledge, this 
case is the first reported patient with both 
hepatitis and pancreatitis induced by 
Hydroxycut. 
Our patient’s biopsy showed mixed 
hepatocellular and cholestatic liver injury. 
However, liver injury is nonspecific and can 
be of either pattern.6 The temporal 
relationship of exposure to the offending 
agent and resolution of symptoms is the 
most reliable marker for the diagnosis of 
drug-induced hepatitis. As in most of the 
reported cases with Hydroxycut, the liver 
function tests improve after drug cessation. 
Our patient did not have evidence of 
gallstones or positive blood alcohol level on 
admission and was not taking any 
medications known to cause acute 
pancreatitis other than Hydroxycut.7-10 Our 
case was unique in that the patient presented 
with both hepatitis and pancreatitis.   
Due to the increasing use of alternative 
medicines, it is important that they are safe. 
We encourage further investigation of the 
ingredients of Hydroxycut and similar 
weight loss supplements to avoid adverse 
outcomes and establish a safety profile. 
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